These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8870813)

  • 61. Metabolic abnormalities in first-degree relatives of type 2 diabetics.
    Di Pietro S; Suraci C
    Boll Soc Ital Biol Sper; 1990 Jul; 66(7):631-8. PubMed ID: 2083058
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Importance of hypercoagulability over hyperglycemia for vascular complication in type 2 diabetes.
    Yamada T; Sato A; Nishimori T; Mitsuhashi T; Terao A; Sagai H; Komatsu M; Aizawa T; Hashizume K
    Diabetes Res Clin Pract; 2000 Jul; 49(1):23-31. PubMed ID: 10808060
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.
    Meigs JB; Mittleman MA; Nathan DM; Tofler GH; Singer DE; Murphy-Sheehy PM; Lipinska I; D'Agostino RB; Wilson PW
    JAMA; 2000 Jan; 283(2):221-8. PubMed ID: 10634338
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state.
    Ariëns RA; de Lange M; Snieder H; Boothby M; Spector TD; Grant PJ
    Lancet; 2002 Feb; 359(9307):667-71. PubMed ID: 11879863
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.
    Jensen CC; Cnop M; Hull RL; Fujimoto WY; Kahn SE;
    Diabetes; 2002 Jul; 51(7):2170-8. PubMed ID: 12086947
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
    Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
    Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prandial glucose effectiveness and fasting gluconeogenesis in insulin-resistant first-degree relatives of patients with type 2 diabetes.
    Nielsen MF; Nyholm B; Caumo A; Chandramouli V; Schumann WC; Cobelli C; Landau BR; Rizza RA; Schmitz O
    Diabetes; 2000 Dec; 49(12):2135-41. PubMed ID: 11118017
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
    Gürlek A; Bayraktar M; Kirazli S
    Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia.
    Cadroy Y; Grandjean H; Pichon J; Desprats R; Berrebi A; Fournié A; Boneu B
    Br J Obstet Gynaecol; 1993 May; 100(5):416-20. PubMed ID: 8518239
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hypercoagulation in chronic post-traumatic stress disorder.
    Robicsek O; Makhoul B; Klein E; Brenner B; Sarig G
    Isr Med Assoc J; 2011 Sep; 13(9):548-52. PubMed ID: 21991715
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
    Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
    Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes.
    Eikelboom JW; Weitz JI; Budaj A; Zhao F; Copland I; Maciejewski P; Johnston M; Yusuf S
    Eur Heart J; 2002 Nov; 23(22):1771-9. PubMed ID: 12419297
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Haemostatic and lipid determinants of prothrombin fragment F1.2 and D-dimer in plasma.
    MacCallum PK; Cooper JA; Martin J; Howarth DJ; Meade TW; Miller GJ
    Thromb Haemost; 2000 Mar; 83(3):421-6. PubMed ID: 10744148
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Coagulation and fibrinolysis during laparoscopic cholecystectomy.
    Rahr HB; Fabrin K; Larsen JF; Thorlacius-Ussing O
    Thromb Res; 1999 Feb; 93(3):121-7. PubMed ID: 10030828
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intracellular skeletal muscle glucose metabolism is differentially altered by dexamethasone treatment of normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE; Alford F; Vaag A; Handberg A; Beck-Nielsen H
    Metabolism; 1999 Sep; 48(9):1128-35. PubMed ID: 10484052
    [TBL] [Abstract][Full Text] [Related]  

  • 77. D-dimer, plasminogen activator inhibitor-1, prothrombin fragments and protein C - role in prothrombotic state of colorectal cancer.
    Mytnik M; Stasko J
    Neoplasma; 2011; 58(3):235-8. PubMed ID: 21391740
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
    Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.
    Caballero AE; Arora S; Saouaf R; Lim SC; Smakowski P; Park JY; King GL; LoGerfo FW; Horton ES; Veves A
    Diabetes; 1999 Sep; 48(9):1856-62. PubMed ID: 10480619
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood.
    Kalweit GA; Feindt P; Micek M; Gams E; Hellstern P
    Thromb Res; 2000 Feb; 97(3):105-11. PubMed ID: 10680641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.